Q9P2K8 (E2AK4_HUMAN) Homo sapiens (Human)

eIF-2-alpha kinase GCN2 UniProtKBInterProSTRINGInteractive Modelling

1649 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

8 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib) Heteromer
584-1006
38O;
Assess
CryoEM structure of the HisRS-like domain of human GCN2homo-2-mer1011-1493
Assess
Crystal structure of the RWD domain of human GCN2 - 2homo-2-mer17-139
Assess
Crystal structure of the RWD domain of human GCN2 - 1homo-2-mer17-138
Assess
Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agentsmonomer584-1004
KA7;
Assess
Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agentsmonomer584-1003
KA4;
Assess
Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agentsmonomer584-1002
KAV;
Assess
GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2monomer583-998
G41;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8t7t.1.Ahomo-2-mer0.831011-1493
100.00
Assess
7qq6.1.Ahomo-2-mer0.59584-1006
38O;99.68
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28t7t.1.Amonomer0.83983-1465
100.00
Assess
Isoform 27qq6.2.Amonomer0.56584-978
38O;95.90
Assess
Isoform 33fe3.1.Bmonomer0.57289-543
23.51
Assess
Isoform 36hvd.1.Amonomer0.57301-546
26.58
Assess